HPC (Cord Blood, Bloodworks)

N/A

Report date: 2026/01/19 16:37:11

Base Information

Drug NameHPC (Cord Blood, Bloodworks)
Drug Alias Name脐带血造血祖细胞 （Bloodworks）造血祖细胞 （Bloodworks）
ClassificationCell and gene therapy > Cell therapy > Source of cells > Umbilical cord blood-derived
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsHematopoietic stem cell transplantation (HSCT)
Global Approved IndicationsHematopoietic stem cell transplantation (HSCT)
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2016/01/28
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBloodworks Northwest
China Registration ClassN/A

Develop Information

Active CompaniesBloodworks Northwest
Inactive CompaniesN/A
Active IndicationsHematopoietic stem cell transplantation (HSCT)
Inactive IndicationsN/A

Other Information

ATC CodeB05AX04
Related LinksN/A